Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-antioxidant status

Blood Cells, Molecules, and Diseases

Volumn 46, Issue 3, 2011, Pages 220-225

  Gizi, Anna ^a   Papassotiriou, Ioannis ^a   Apostolakou, Filia ^a   Lazaropoulou, Christina ^a   Papastamataki, Maria ^a   Kanavaki, Ino ^a   Kalotychou, Vassiliki ^b   Goussetis, Evgenios ^a   Kattamis, Antonios ^b   Rombos, Ioannis ^b   Kanavakis, Emmanuel ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Glutathione; Malondialdehyde; Nitric oxide; Non transferrin bound iron; Oxidative stress; Sickle cell disease

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROXYUREA; MALONALDEHYDE; NITRIC OXIDE; OXYGEN RADICAL; RETINOL; SUPEROXIDE DISMUTASE; TRANSFERRIN;

ADULT; ANTIOXIDANT ACTIVITY; APHERESIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL ASSAY; CELL LYSATE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SICKLE CELL ANEMIA; SPECTROFLUOROMETRY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; FEMALE; FREE RADICALS; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOREDUCTASES; YOUNG ADULT;

EID: 79952107760     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2011.01.002     Document Type: Article

References (32)

1. Epstein F. Pathogenesis and treatment of sickle cell disease. N. Engl. J. Med. 1997, 337:762-769.
2. Aslan M., Thornley-Brown D., Freeman B. Reactive species in sickle cell disease. Ann. N.Y. Acad. Sci. 2000, 899:375-391.
3. Sheng K., Shariff M., Hebbel R. Comparative oxidation of hemoglobins A and S. Blood 1998, 91:3467-3470.
4. Klings E., Farber H. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir. Res. 2001, 2:280-285.
5. Hebbel R., Morgan W., Eaton J., Hedlung B. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl Acad. Sci. USA 1988, 85:237-241.
6. Hebbel R. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 1991, 77:214-237.
7. Rice-Evans C., Omorphos S., Baysal E. Sickle cell membranes and oxidative damage. Biochem. J. 1986, 237:265-269.
8. Dalle-Donne I., Rossi R., Colombo R., Giustariny D., Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52:611-623.
9. Wood K., Granger D.N. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin. Exp. Pharmacol. Physiol. 2007, 34:926-932.
10. Voskaridou E., Christoulas D., Bilalis A., Plata E., Varvagiannis K., Stamatopoulos G., Sinopoulou K., Balassopoulou A., Loukopoulos D., Terpos E. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010, 115:2354-2363.
11. Rossi R., Dalle-Donne I., Milzani A., Giustariny D. Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. Clin. Chem. 2006, 52:1-9.
12. Repka T., Hebbel R. Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood 1991, 78:2753-2758.
13. Walter P., Fung E., Killilea D., Jiang Q., Hudes M., Madden J., Porter J., Evans P., Vichinsky E., Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with β-thalassaemia or sickle cell disease. Br. J. Haematol. 2006, 135:254-263.
14. Hummel S.G., Fischer A.J., Martin S.M., Schafer F.Q., Buettner G.R. Nitric oxide as a cellular antioxidant: a little goes a long way. Free Radiol. Biol. Med. 2006, 40:501-506.
15. Beevi S.S.S., Rasheed A.M.H., Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J. Clin. Oncol. 2004, 34:379-385.
16. Amer J., Ghoti H., Rachmilewitz C., Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br. J. Haematol. 2005, 132:108-113.
17. Bursell S.-E., King G.L. The potential use of glutathionyl hemoglobin as a clinical marker of oxidative stress. Clin. Chem. 2000, 46:145-146.
18. Tsantes A., Bonovas S., Travlou A., Sitaras N. Redox imbalance, macrocytosis, and RBC homeostasis. Antioxid. Redox Signal. 2006, 8:1205-1216.
19. Dumaswala U., Zhuo L., Mahajan S., Nair P., Shertzer H., Dibello P., Jacobsen D. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am. J. Physiol. Cell Physiol. 2001, 280:867-873.
20. Kutlar A. Sickle cell disease: a multigenic perspective of a single gene disorder. Hematology 2005, 10:92-99.
21. Schafer F., Buettner G. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radiol. Biol. Med. 2001, 30:1191-1212.
22. Chan A., Chow C., Chiu D. Interaction of antioxidants and their implication in genetic anemia. Exp. Biol. Med. 1999, 222:274-282.
23. Thom G.G.A., Kallanagowdar C., Somjee S.S., Velez M.C., Yu L.C., Hempe J.M. Characterization of S-glutathionyl hemoglobin in homozygous sickle cell disease. J Pediatr. Hematol./ Oncol 2009, 31:895-900.
24. Skenderi K.P., Tsironi M., Lazaropoulou C., Anastasiou C.A., Matalas A.-L., Kanavaki I., Thalmann M., Goussetis E., Papassotiriou I., Chrousos G.P. Changes in free radical generation and antioxidant capacity during ultramarathon foot race. Eur. J. Clin. Investig. 2008, 38:159-165.
25. Rusanova I., Escames G., Cossio G., de Borace R.G., Moreno B., Chahboune M., López L.C., Díez T., Acuña-Castoviejo D. Oxidative stress status, clinical outcome, and beta globin gene cluster haplotypes in pediatric patients with sickle cell disease. Eur. J. Haematol. 2010, 85:529-537.
26. Pavlatou M.G., Papastamataki M., Apostolakou F., Papassotiriou I., Tentolouris N. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. Metabolism 2009, 58:1657-1662.
27. Mantovani G., Madeddu C., Gramignano G., Serpe R., Massa E., Deiana L., Macciò A. An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: background and design of an ongoing, phase III randomized clinical trial. Support. Cancer Ther. 2007, 4:163-167.
28. Aslan M., Canatan D. Modulation of redox pathways in neutrophils from sickle cell disease patients. Exp. Hematol. 2008, 36:1535-1544.
29. Garel M.C., Domenget C., Caburi-Martin J., Prehu C., Galacteros F., Beuzard Y. Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization. J. Biol. Chem. 1986, 261:14704-14709.
30. Lii C.K., Hung C.N. Protein thiol modifications of human red blood cells treated with t-butyl hydroperoxide. B B A 1997, 1339:147-156.
31. Dudley R.W.R., Khairallah M., Mohammed S., Lands L., Des Rosiers C., Petrof B.J. Dynamic responses of the glutathione system to acute oxidative stress in dystrophic mouse (mdx) muscles. Am J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:704-710.
32. Wood K., Hsu L., Gladwin M. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic. Biol. Med. 2008, 44:1506-1528.